Zimmer Biomet Holdings (ZBH) EBITDA Margin (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted EBITDA Margin of 14.98% for Q2 2026, down 16.24% on a QoQ basis from 17.88% in Q1 2026, and up 54.0% year-over-year from 9.73% in Q2 2025.
Powered by 
Analysis
Zimmer Biomet Holdings (ZBH) EBITDA Margin (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings has reported EBITDA Margin for 18 years, with the latest figure at 14.98% in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 54.0% year-over-year to 14.98% in Q2 2026; TTM through Jun 2026 was 14.16%, a 193.0% decrease from a year earlier, with the FY2025 full-year figure at 13.34%, down 340.0% from the prior year.
- EBITDA Margin was 14.98% for Q2 2026 at Zimmer Biomet Holdings, down from 17.88% in the prior quarter.
- The five-year high for EBITDA Margin was 19.23% in Q4 2024, with the low at 1.55% in Q4 2022.
- Average EBITDA Margin over 5 years is 14.64%, with a median of 15.32% recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: EBITDA Margin soared 1981 bps in 2023, then slumped 1234 bps in 2025.
- Over 5 years, EBITDA Margin stood at 1.55% in 2022, then soared by 1277 bps to 18.26% in 2023, then rose by 5 bps to 19.23% in 2024, then slumped by 64 bps to 6.89% in 2025, then surged by 118 bps to 14.98% in 2026.
- The last three EBITDA Margin figures came in at 14.98% (Q2 2026), 17.88% (Q1 2026), and 6.89% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.51 Bn | 177.91 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 124.70 Bn | 119.48 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 106.08 Bn | 102.61 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.53 Bn | 65.99 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.51 Bn | 45.26 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.90 Bn | 32.44 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.09 Bn | 30.14 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.06 Bn | 20.58 Bn | 684.20 Mn | 19.15% |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | 14.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.98% |
| Mar 31, 2026 | 17.88% |
| Dec 31, 2025 | 6.89% |
| Sep 30, 2025 | 17.55% |
| Jun 30, 2025 | 14.44% |
| Mar 31, 2025 | 15.31% |
| Dec 31, 2024 | 19.23% |
| Sep 30, 2024 | 15.32% |
| Jun 30, 2024 | 18.09% |
| Mar 31, 2024 | 14.07% |
| Dec 31, 2023 | 18.26% |
| Sep 30, 2023 | 15.20% |
| Jun 30, 2023 | 17.63% |
| Mar 31, 2023 | 17.88% |
| Dec 31, 2022 | -1.55% |
| Sep 30, 2022 | 14.69% |
| Jun 30, 2022 | 15.76% |
| Mar 31, 2022 | 11.93% |
| Dec 31, 2021 | 7.53% |
| Sep 30, 2021 | 14.42% |